Ancon Medical

General information

Ancon Medical Inc. is a high tech “Medical Device” Corporation offering revolutionary new Nanoparticle Biomarker Tagging detection technology which provides unprecedented levels of sensitivity (much lower than parts per trillion), presenting a unique solution to the Healthcare industry.

In particular, Ancon Medical Inc. opens door for early stage diagnostics of Lung Cancer, Tuberculosis and other illnesses. Early diagnosis is often crucial to providing effective healthcare and increasing a patient’s chances of recovery and quality of life. Ancon technology has been designed to be compatible with and deliverable to point of care clinics.

Ancon’s unprecedented sensitivity is based on a novel, proprietary technology known as Nanoparticle Biomarker Tagging (NBT). Following the discovery of a method to count individual ions, Ancon’s team of engineers, scientists and business experts have developed the technology over the last 10 years and established an impressive portfolio of IP including UK and US patents.

Ancon Medical has close working relations with global market leaders and renowned public and private laboratories. Ancon Medical has received numerous grants and awards from public bodies.

Ancon Medical Inc. is a Minnesotan Corporation located in Minneapolis, Minnesota, USA.